This is a preview of subscription content, log in via an institution to check access.
References
Ginsberg RJ and Rubinstein LV (1995) Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60: 615–622
Arriagada R et al. (2004) Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350: 351–360
Douillard JY et al. (2005) ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small cell lung cancer (NSCLC) patients (pts): Final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association. [abstract #7013] J Clin Oncol 23: 624s
Strauss GM et al. (2004) Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): report of Cancer and Leukemia Group B (CALGB) Protocol 9633. [abstract #7019] J Clin Oncol 22: 621s
Acknowledgements
The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Azzoli, C. Can adjuvant chemotherapy improve survival in patients with early-stage, resected non-small-cell lung cancer?. Nat Rev Clin Oncol 2, 552–553 (2005). https://doi.org/10.1038/ncponc0350
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0350
- Springer Nature Limited
This article is cited by
-
More pronounced salt dependence and higher reactivity for platination of the hairpin r(CGCGUUGUUCGCG) compared with d(CGCGTTGTTCGCG)
JBIC Journal of Biological Inorganic Chemistry (2006)